CardioGenesis Transmyocardial Revascularization 1-Year Follow-Up Study
A Multi-Center Single Arm One Year Prospective Follow-Up of Patients Treated With the CryoLife CardioGenesis Holmium:YAG Laser System for Transmyocardial Revascularization (The TMR 365 Study)
Sponsor: CryoLife, Inc.
This observational or N/A phase trial investigates Class IV Angina and is currently completed. CryoLife, Inc. leads this study, which shows 11 recorded versions since 2016 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Mar 2022 — Jul 2024 [monthly]
Completed
-
Apr 2021 — Mar 2022 [monthly]
Completed
Status: Unknown Status → Completed
-
Jan 2021 — Apr 2021 [monthly]
Unknown Status
▶ Show 6 earlier versions
-
Oct 2020 — Jan 2021 [monthly]
Unknown Status
Status: Active Not Recruiting → Unknown Status
-
Oct 2018 — Oct 2020 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Jun 2018 — Oct 2018 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Oct 2017 — Apr 2018 [monthly]
Recruiting NA
-
Jan 2017 — Oct 2017 [monthly]
Recruiting NA
First recorded
Mar 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- CryoLife, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .